PAK1 and posterior cortical atrophy: Collectively, these results suggest that VAV2 promotes PCa progression by activating the PAK1/AKT signaling pathway while simultaneously stabilizing AR/ARv7 proteins, sustaining their function even in the presence of Enzalutamide.